Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors

Claus J. Loland, Rajeev I. Desai, Mu-Fa Zou, Jianjing Cao, Peter Grundt, Klaus Gerstbrein, Harald H. Sitte, Amy Hauck Newman, Jonathan L. Katz and Ulrik Gether
Molecular Pharmacology March 2008, 73 (3) 813-823; DOI: https://doi.org/10.1124/mol.107.039800
Claus J. Loland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajeev I. Desai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mu-Fa Zou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianjing Cao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Grundt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Gerstbrein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald H. Sitte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Hauck Newman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan L. Katz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrik Gether
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 73 no. 3 813-823
DOI 
https://doi.org/10.1124/mol.107.039800
PubMed 
17978168

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received July 13, 2007
  • Accepted October 31, 2007
  • Published online February 21, 2008.

Article Versions

  • Earlier version (October 31, 2007 - 11:17).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Claus J. Loland,
  2. Rajeev I. Desai,
  3. Mu-Fa Zou,
  4. Jianjing Cao,
  5. Peter Grundt,
  6. Klaus Gerstbrein,
  7. Harald H. Sitte,
  8. Amy Hauck Newman,
  9. Jonathan L. Katz and
  10. Ulrik Gether
  1. Molecular Neuropharmacology Group, Department of Neuroscience and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark (C.J.L., U.G.); Psychobiology (R.I.D., J.L.K.) and Medicinal Chemistry Sections (M.-F.Z., J.C., P.G., A.H.N.), Medications Discovery Research Branch, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland; and Institute for Pharmacology, Center for Biomolecular Medicine and Pharmacology, Medical University Vienna, Vienna, Austria (K.G., H.H.S.)
  1. Address correspondence to:
    Dr. Claus J. Loland, Molecular Neuropharmacology Group, Department of Neuroscience and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark. E-mail: claus{at}neuropharm.ku.dk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2007 to June 2023

AbstractFullPdf
Oct 2007404
Nov 2007270132
Dec 200711070
Jan 200812045
Feb 2008551779
Mar 2008472750
Apr 2008333348
May 2008132425
Jun 2008361523
Jul 2008131926
Aug 2008101517
Sep 2008191517
Oct 2008392323
Nov 2008171525
Dec 200841519
Jan 2009121210
Feb 20091636
Mar 2009252427
Apr 2009232421
May 2009162127
Jun 2009122911
Jul 2009102113
Aug 2009796
Sep 200982514
Oct 2009102227
Nov 20098159
Dec 20091095
Jan 20101029
Feb 2010141310
Mar 201023812
Apr 2010493
May 201013139
Jun 201015144
Jul 20108156
Aug 201081510
Sep 20101165
Oct 20109196
Nov 2010112015
Dec 2010895
Jan 2011101719
Feb 2011151811
Mar 2011161412
Apr 201113119
May 201171810
Jun 2011101110
Jul 2011152516
Aug 2011154922
Sep 2011151222
Oct 2011191321
Nov 2011173315
Dec 2011171718
Jan 2012221317
Feb 2012141712
Mar 201214813
Apr 2012251725
May 2012111324
Jun 201211613
Jul 2012151021
Aug 2012171220
Sep 2012131417
Oct 2012162523
Nov 2012112218
Dec 2012121317
Jan 2013371715
Feb 2013161910
Mar 2013171215
Apr 2013221725
May 2013231318
Jun 20138814
Jul 2013494
Aug 20131064
Sep 20132288
Oct 2013202011
Nov 201311178
Dec 2013141510
Jan 20141284
Feb 20141488
Mar 20141098
Apr 20141095
May 2014885
Jun 201410147
Jul 201417187
Aug 20146114
Sep 2014111214
Oct 2014152211
Nov 201413138
Dec 201411185
Jan 20151699
Feb 20151945
Mar 201514144
Apr 201519187
May 201521137
Jun 201525105
Jul 201522912
Aug 20151977
Sep 20151283
Oct 2015694
Nov 20151165
Dec 20151215
Jan 201622146
Feb 2016171114
Mar 20161797
Apr 20164058
May 201624106
Jun 201612106
Jul 2016988
Aug 20161746
Sep 2016131215
Oct 20161135
Nov 201692514
Dec 201631613
Jan 20171194
Feb 20171213
Mar 20174317
Apr 20174125
May 201782010
Jun 20172166
Jul 20177144
Aug 20176293
Sep 20173177
Oct 20175305
Nov 20177206
Dec 201710115
Jan 20187217
Feb 20181217
Mar 201852512
Apr 201832812
May 201862814
Jun 2018185
Jul 201831818
Aug 20184164
Sep 20183178
Oct 20184204
Nov 20181248
Dec 20181463
Jan 20191755
Feb 20191623
Mar 20192068
Apr 20192167
May 2019776
Jun 20191737
Jul 2019833
Aug 20193446
Sep 20192702
Oct 20191932
Nov 20192663
Dec 20192451
Jan 20201031
Feb 20201523
Mar 202011164
Apr 20202075
May 2020910
Jun 2020742
Jul 20201731
Aug 2020623
Sep 20201121
Oct 2020770
Nov 20201735
Dec 20203864
Jan 202118144
Feb 202121235
Mar 20214874
Apr 20215376
May 202139102
Jun 20219171
Jul 20211543
Aug 202111166
Sep 20211483
Oct 20211560
Nov 2021844
Dec 20212621
Jan 20224364
Feb 2022864
Mar 20221163
Apr 20221921
May 20221633
Jun 20222222
Jul 20221132
Aug 20221521
Sep 20221395
Oct 202212115
Nov 20221242
Dec 20221941
Jan 202325136
Feb 20232641
Mar 20233731
Apr 20232033
May 20231444
Jun 2023010

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 73 (3)
Molecular Pharmacology
Vol. 73, Issue 3
1 Mar 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors

Claus J. Loland, Rajeev I. Desai, Mu-Fa Zou, Jianjing Cao, Peter Grundt, Klaus Gerstbrein, Harald H. Sitte, Amy Hauck Newman, Jonathan L. Katz and Ulrik Gether
Molecular Pharmacology March 1, 2008, 73 (3) 813-823; DOI: https://doi.org/10.1124/mol.107.039800

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors

Claus J. Loland, Rajeev I. Desai, Mu-Fa Zou, Jianjing Cao, Peter Grundt, Klaus Gerstbrein, Harald H. Sitte, Amy Hauck Newman, Jonathan L. Katz and Ulrik Gether
Molecular Pharmacology March 1, 2008, 73 (3) 813-823; DOI: https://doi.org/10.1124/mol.107.039800
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Action of Org 34167 on HCN channels
  • The effects of echinocystic acid on Kv7 channels
  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics